192 related articles for article (PubMed ID: 34560543)
1. Cancer driver gene and non-coding RNA alterations as biomarkers of brain metastasis in lung cancer: A review of the literature.
Karimpour M; Ravanbakhsh R; Maydanchi M; Rajabi A; Azizi F; Saber A
Biomed Pharmacother; 2021 Nov; 143():112190. PubMed ID: 34560543
[TBL] [Abstract][Full Text] [Related]
2. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance.
Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB
Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-330-3p promotes brain metastasis and epithelial-mesenchymal transition via GRIA3 in non-small cell lung cancer.
Wei C; Zhang R; Cai Q; Gao X; Tong F; Dong J; Hu Y; Wu G; Dong X
Aging (Albany NY); 2019 Sep; 11(17):6734-6761. PubMed ID: 31498117
[TBL] [Abstract][Full Text] [Related]
4. Response rate of patients with baseline brain metastases from recently diagnosed non-small cell lung cancer receiving radiotherapy according to EGFR, ALK and KRAS mutation status.
Arrieta O; Ramírez-Tirado LA; Caballé-Perez E; Mejia-Perez A; Zatarain-Barrón ZL; Cardona AF; Lozano-Ruíz F; Segura-González M; Cruz-Rico G; Maldonado F; Rosell R
Thorac Cancer; 2020 Apr; 11(4):1026-1037. PubMed ID: 32072746
[TBL] [Abstract][Full Text] [Related]
5. miRNA-197 and miRNA-184 are associated with brain metastasis in EGFR-mutant lung cancers.
Remon J; Alvarez-Berdugo D; Majem M; Moran T; Reguart N; Lianes P
Clin Transl Oncol; 2016 Feb; 18(2):153-9. PubMed ID: 26199015
[TBL] [Abstract][Full Text] [Related]
6. Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutations.
Wang H; Wang Z; Zhang G; Zhang M; Zhang X; Li H; Zheng X; Ma Z
Cancer Med; 2020 Jan; 9(2):487-495. PubMed ID: 31769228
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of gene mutations detected by next generation exome sequencing in brain metastases of lung adenocarcinoma.
Preusser M; Berghoff AS; Koller R; Zielinski CC; Hainfellner JA; Liebmann-Reindl S; Popitsch N; Geier CB; Streubel B; Birner P
Eur J Cancer; 2015 Sep; 51(13):1803-11. PubMed ID: 26164066
[TBL] [Abstract][Full Text] [Related]
8. [Non-coding RNA in malignant tumors. A new world of tumor biomarkers and target structures in cancer cells].
Diederichs S
Pathologe; 2010 Oct; 31 Suppl 2():258-62. PubMed ID: 20711585
[TBL] [Abstract][Full Text] [Related]
9. Non-coding RNAs for medical practice in oncology.
Setoyama T; Ling H; Natsugoe S; Calin GA
Keio J Med; 2011; 60(4):106-13. PubMed ID: 22200634
[TBL] [Abstract][Full Text] [Related]
10. Systematic review and meta-analysis of lung cancer brain metastasis and primary tumor receptor expression discordance.
Tonse R; Rubens M; Appel H; Tom MC; Hall MD; Odia Y; McDermott MW; Ahluwalia MS; Mehta MP; Kotecha R
Discov Oncol; 2021 Nov; 12(1):48. PubMed ID: 35201504
[TBL] [Abstract][Full Text] [Related]
11. A Review of Recent Advances in the Molecular Mechanisms Underlying Brain Metastasis in Lung Cancer.
Guan C; Zhang X; Yu L
Mol Cancer Ther; 2024 May; 23(5):627-637. PubMed ID: 38123448
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status.
Kim H; Yang JM; Jin Y; Jheon S; Kim K; Lee CT; Chung JH; Paik JH
Oncotarget; 2017 Jan; 8(5):8484-8498. PubMed ID: 28035073
[TBL] [Abstract][Full Text] [Related]
13. Progress of non-coding RNAs in triple-negative breast cancer.
Liu J; Zhao G; Liu XL; Zhang G; Zhao SQ; Zhang SL; Luo LH; Yin DC; Zhang CY
Life Sci; 2021 May; 272():119238. PubMed ID: 33600860
[TBL] [Abstract][Full Text] [Related]
14. Non-coding RNA profile in lung cancer.
Ghafouri-Fard S; Shoorei H; Branicki W; Taheri M
Exp Mol Pathol; 2020 Jun; 114():104411. PubMed ID: 32112788
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
[TBL] [Abstract][Full Text] [Related]
16. Non-coding RNAs in lung cancer: emerging regulators of angiogenesis.
Liao Y; Wu X; Wu M; Fang Y; Li J; Tang W
J Transl Med; 2022 Aug; 20(1):349. PubMed ID: 35918758
[TBL] [Abstract][Full Text] [Related]
17. EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer.
Tomasini P; Serdjebi C; Khobta N; Metellus P; Ouafik L; Nanni I; Greillier L; Loundou A; Fina F; Mascaux C; Barlesi F
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999344
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer.
Lu Y; Govindan R; Wang L; Liu PY; Goodgame B; Wen W; Sezhiyan A; Pfeifer J; Li YF; Hua X; Wang Y; Yang P; You M
Carcinogenesis; 2012 May; 33(5):1046-54. PubMed ID: 22331473
[TBL] [Abstract][Full Text] [Related]
19. Role of non-coding RNAs in pancreatic cancer: the bane of the microworld.
Tang YT; Xu XH; Yang XD; Hao J; Cao H; Zhu W; Zhang SY; Cao JP
World J Gastroenterol; 2014 Jul; 20(28):9405-17. PubMed ID: 25071335
[TBL] [Abstract][Full Text] [Related]
20. Non-coding landscapes of colorectal cancer.
Ragusa M; Barbagallo C; Statello L; Condorelli AG; Battaglia R; Tamburello L; Barbagallo D; Di Pietro C; Purrello M
World J Gastroenterol; 2015 Nov; 21(41):11709-39. PubMed ID: 26556998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
